Skip to main content

Table 1 Demographic, Tumor and Treatment Characteristics of 46 patients with RSTS who underwent surgical resection at the Department of General- and Visceral Surgery, University of Freiburg from 2001 to 2014

From: Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma

 

N (% of total)

Age (years)

  < 55

20 (43.5%)

  > 55

26 (56.5%)

Gender

 Male

25 (54.3%)

 Female

21 (45.7%)

Presentation

 Primary

24 (52.2%)

 Recurrent

22 (47.8%)

Tumor Grade

 High

22 (47.8%)

 Low

24 (52.2%)

Histologic subtype

 Liposarcoma

34 (73.9%)

 Leiomyosarcoma

7 (15.2%)

 PUS

3 (6.5%)

 Other

2 (4.3%)

Tumor size

  < 5 cm

2 (4.3%)

 5–10 cm

7 (15.2%)

 10–20 cm

13 (28.3%)

  > 20 cm

24 (52.2%)

Resection status

 R0

28 (60.9%)

 R1

11 (23.9%)

 R2

7 (15.2%)

 Local resection

18 (29.1%)

 Visceral resection

28 (60.9%)

Radiotherapy

 Radiotherapy + surgery

23 (50%)

 No radiotherapy

23 (50%)

Chemotherapy

 Neoadjuvant

2 (10.9%)

 Adjuvant

5 (4.3%)

 Both

1 (2.2%)

 None

39 (84.8%)

  1. N number of patients